Clinical trial
Phase 1/2a Study of KH001 in Dentin Hypersensitivity Patients
NCT04804514 is registered in ClinicalTrials.gov with HysensBio Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 1/2a Study of KH001 in Dentin Hypersensitivity Patients
- Lead sponsor
- HysensBio Co., Ltd
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- June 14, 2021
- Completion date
- March 3, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.